Glen Harbor Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $294K | Hold |
3,652
| – | – | 0.01% | 887 |
|
|
2019
Q2 | $265K | Sell |
3,652
-660
| -15% | -$47.9K | 0.01% | 933 |
|
|
2019
Q1 | $403K | Sell |
4,312
-44
| -1% | -$4.11K | 0.01% | 755 |
|
|
2018
Q4 | $318K | Sell |
4,356
-41,910
| -91% | -$3.06M | 0.01% | 784 |
|
|
2018
Q3 | $4.05M | Sell |
46,266
-4,642
| -9% | -$406K | 0.08% | 238 |
|
|
2018
Q2 | $5.01M | Buy |
50,908
+12,166
| +31% | +$1.2M | 0.11% | 189 |
|
|
2018
Q1 | $4.61M | Buy |
+38,742
| New | +$4.61M | 0.1% | 189 |
|